[The association of paraoxonase 2 gene C311S variant with ischemic stroke in Chinese type 2 diabetes mellitus patients].
- X. Wang, Y. Xue, S. Wen, N. Zhang, Zhong Ji, S. Pan
- Zhonghua yi xue yi chuan xue za zhi = Zhonghua…
- 1 June 2003
OBJECTIVE To investigate the association between the C311S polymorphism of paraoxonase 2 (PON2) gene and ischemic stroke in Chinese type 2 diabetes mellitus (T2DM) patients. METHODS A case-control… Expand
Efficacy and safety of apatinib plus docetaxel as the second or above line treatment in advanced nonsquamous NSCLC
Abstract Background: Apatinib is an oral small-molecule tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor 2 (VEGFR-2). Some clinical trials have demonstrated that… Expand
90 Autophagy-related Proteins Impact Outcomes in Acute Myelogenous Leukemia: Proteomic Analysis and Biological Correlates
Efficacy analyses of central laboratory pCR results from the LILAC study comparing the biosimilar ABP 980 and trastuzumab.
583Background: The phase 3 LILAC Study compared ABP 980 with trastuzumab (TRAS) on pathologic complete response (pCR) in women with HER2+ early breast cancer. The primary efficacy results, based on… Expand
Clinical study on the indications of qualifying the postoperative flying personnel with malignant tumor
Objective To study and discuss the safety standard of flying qualification for the postoperative flying personnel with malignant tumor. Methods Related case history in past 38 years was… Expand
Combined treatment of apatinib with docetaxel as post second-line therapy in advanced non-squamous non-small cell lung cancer(NSCLC): Results from a pilot, multi-center study.
e21213Background: There is no effective treatment strategy for patients with advanced non-small cell lung cancer (NSCLC) who experienced progression with one or two lines of chemotherapy. Apatinib,...